Blood Medicine: Blowing the Whistle on One of the Deadliest Prescription Drugs Ever

Blood Medicine: Blowing the Whistle on One of the Deadliest Prescription Drugs Ever
Kathleen Sharp (Auteur)

Acheter neuf : EUR 13,21 (as of 12/19/2012 03:58 PST)
13 neuf & d'occasion a partir de EUR 8,67 (as of 12/19/2012 03:58 PST)

(Consultez la liste Cadeaux les plus demandes dans la rubrique Ethics & Professional Responsibility pour des informations officielles sur le classement actuel de ce produit.)

Description du produit

""Blood Feud" rivals "A Civil Action" for best non-fiction book of the past twenty years." -- John Lescroart, "New York Times" bestselling author of "Damage" Procrit seemed like a biotech miracle, promising a golden age in medical care. Developed in the 1980s by Amgen and licensed to the pharmaceutical giant, Johnson & Johnson, the drug (AKA Epogen and Aranesp) soon generated billions in annual revenue--and still does. Mark Duxbury was a J&J salesman who believed in the blood-booster, setting record sales and winning company awards. Then Duxbury started to learn unsavory truths about Procrit and J&J's business practices. He was fired and filed a whistleblower suit to warn the public. When Jan Schlichtman ("A Civil Action") learned of Duxbury's crusade, he signed on. Now, he's fighting on behalf of cancer patients and for every American who trusts Big Pharma with his life.